Balanced news tone
News Sentiment
IMC sentiment intelligence
Immuron Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
95/100 classification confidence.
directly relevant articles
high-authority source matches
+19.4% over one week, +26.5% over four weeks, trend active, and below fair value.
Immuron FY26 sales rise 6% to AUD$7.7 million led by Australia
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Immuron FY26 sales rise 6% to AUD$7.7 million led by Australia
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 10:39
- Source
- scanx.trade
Immuron's Travelan Sales Grow for Four Straight Quarters
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 10:00
- Source
- Stock Titan
Immuron (ASX: IMC) Delivers Another Year of Sales Growth as Travelan Gains Momentum
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 16 Jul 2026 06:22
- Source
- Kalkine Media
Australia's Immuron sales reach $7.7 million in FY26
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 02:32
- Source
- grafa.com
Immuron (NASDAQ: IMRN) advances IMM-529 CDI drug with new partnering push
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 12:01
- Source
- Stock Titan
Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 10:51
- Source
- markets.businessinsider.com
Immuron seeks partner for gut infection drug IMM-529
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Stock Titan
Immuron (NASDAQ: IMRN) now has 322.8M ordinary shares on issue
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Stock Titan
Immuron (ASX: IMC): Advancing Gastrointestinal Product Portfolio Across Multiple Markets
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Kalkine Media
Immuron (NASDAQ: IMRN) responds to ASX query on share price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- Stock Titan
Global Momentum Continues as Immuron Delivers Double-Digit Q3 Sales Growth in Australia
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- smallcaps.com.au
Insights: Immuron Ltd (ASX:IMC)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Oct 2025 15:44
- Source
- smallcaps.com.au
Immuron launches PROIBS in Australia to support people living with IBS
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Oct 2025 07:00
- Source
- BiotechDispatch
Immuron Limited (ASX: IMC) - Share Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Feb 2020 21:14
- Source
- intelligentinvestor.com.au
IMC Stock Price and Chart — ASX:IMC
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jul 2017 03:43
- Source
- TradingView